FindTrial
Sign In

Clinical evaluation of dried blood spots for the determination of tamoxifen and endoxifen levels

Clinical evaluation of dried blood spots for the determination of tamoxifen and endoxifen levels - Tamoxifen and endoxifen in DBS

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37023
Enrollment
50
Registered
2012-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer mammacarcinoma

Interventions

None listed

Sponsors

Slotervaartziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Treated with tamoxifen - Age 18 years or older - Able and willing to give informed consent - Able and willing to undergo a fingerprick for dried blood spot sampling

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Ratio of the concentration tamoxifen and endoxifen in serumsamples and concentration of tamoxifen and endoxifen in dried blood spot samples.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)